842
Views
17
CrossRef citations to date
0
Altmetric
Case Report

Voriconazole-associated visual disturbances and hallucinations

, , &
Pages 80-82 | Received 23 Dec 2014, Accepted 14 Feb 2015, Published online: 23 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aditya K. Gupta, Sandor Haas-Neill & Mesbah Talukder. (2023) The safety of oral antifungals for the treatment of onychomycosis. Expert Opinion on Drug Safety 0:0, pages 1-10.
Read now
Kathleen M. Job, Jared Olson, Chris Stockmann, Jonathan E. Constance, Elena Y. Enioutina, Joseph E. Rower, Matthew W. Linakis, Alfred H. Balch, Tian Yu, Xiaoxi Liu, Emily A. Thorell & Catherine M. T. Sherwin. (2016) Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. Expert Review of Anti-infective Therapy 14:8, pages 731-746.
Read now

Articles from other publishers (15)

Thomas C. McHale, David R. Boulware, John Kasibante, Kenneth Ssebambulidde, Caleb P. Skipper & Mahsa Abassi. (2023) Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews.
Crossref
Mehwish Mushtaq, Kshaf Fatima, Aneeqa Ahmad, Osama Mohamed Ibrahim, Muhammad Faheem & Yasar Shah. (2023) Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study. Frontiers in Pharmacology 14.
Crossref
Rujiang Zheng, Yu Li, Chuyi Guo, Yuxin Pei, Zhiyong Ke & Libin Huang. (2021) Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review. Frontiers in Pediatrics 9.
Crossref
Frederick “Fritz” T. Fraunfelder & Frederick “Rick” W. Fraunfelder. 2021. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects 19 85 .
Ling-Ning Meng, Jin-Yan Liu, Yu-Ting Wang, Shuai-Shuai Ni & Ming-Jie Xiang. (2020) The discovery of potential phosphopantetheinyl transferase Ppt2 inhibitors against drug-resistant Candida albicans. Brazilian Journal of Microbiology 51:4, pages 1665-1672.
Crossref
Ying‐Kui Jiang, Rui‐Ying Wang, Xuan Wang, Hua‐Zhen Zhao, Ling‐Hong Zhou, Li‐Ping Huang, Ching‐Wan Yip, Jia‐Hui Cheng, Chun‐Xing Que, Chen Jiang & Li‐Ping Zhu. (2020) Genetic polymorphisms of transient receptor potential melastatin 1 correlate with voriconazole‐related visual adverse events . Mycoses 63:6, pages 579-587.
Crossref
Subhajit Dutta & Shweta Jha. 2020. New and Future Developments in Microbial Biotechnology and Bioengineering. New and Future Developments in Microbial Biotechnology and Bioengineering 37 45 .
Yanan Liu, Jing Lu, Jing Sun, Xiaoyu Zhu, Libang Zhou, Zhaoxin Lu & Yingjian Lu. (2019) C16-Fengycin A affect the growth of Candida albicans by destroying its cell wall and accumulating reactive oxygen species. Applied Microbiology and Biotechnology 103:21-22, pages 8963-8975.
Crossref
Sara Belga, Clayton MacDonald, Dima Kabbani, Kelsey Roelofs, Mohammed Wasif Hussain & Carlos Cervera. (2019) When medicine transforms art. Transplant Infectious Disease 21:4.
Crossref
Begoña Fuster-Escrivá, Mercedes Chanzá-Aviñó & Concepción Gimeno-Cardona. (2019) Otomastoiditis por Scedosporium apiospermum. Alucinaciones como efecto adverso del voriconazol. Revista Iberoamericana de Micología 36:3, pages 165-166.
Crossref
Felix Bongomin, Niamh Maguire, Caroline B. Moore, Timothy Felton & Riina Rautemaa‐Richardson. (2019) Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events. Mycoses 62:3, pages 217-222.
Crossref
Giselle C. de Oliveira Santos, Cleydlenne C. Vasconcelos, Alberto J. O. Lopes, Maria do S. de Sousa Cartágenes, Allan K. D. B. Filho, Flávia R. F. do Nascimento, Ricardo M. Ramos, Emygdia R. R. B. Pires, Marcelo S. de Andrade, Flaviane M. G. Rocha & Cristina de Andrade Monteiro. (2018) Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents. Frontiers in Microbiology 9.
Crossref
Gemma Hayes & Lilyann Novak-Frazer. (2016) Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?. Journal of Fungi 2:2, pages 18.
Crossref
. (2016) Voriconazole. Reactions Weekly 1589:1, pages 199-199.
Crossref
Dayna S. McManus. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 243 253 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.